MedPath

SULFACETAMIDE SODIUM, SULFUR

(sodium sulfacetamide 10%, sulfur 5%)

Approved
Approval ID

0e128306-1357-daad-e063-6294a90a760a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 23, 2024

Manufacturers
FDA

Cintex Services, LLC

DUNS: 078304114

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SULFACETAMIDE SODIUM, SULFUR

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code24470-933
Product Classification
G
Generic Name
SULFACETAMIDE SODIUM, SULFUR
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 23, 2024
FDA Product Classification

INGREDIENTS (2)

SULFURActive
Quantity: 50 mg in 1 g
Code: 70FD1KFU70
Classification: ACTIB
SULFACETAMIDE SODIUMActive
Quantity: 100 mg in 1 g
Code: 4NRT660KJQ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SULFACETAMIDE SODIUM, SULFUR - FDA Drug Approval Details